News and Articles

BAMF Health’s nonprofit foundation, FMAB, announced its Founding Board of Directors, which includes statewide leaders, innovators, and development experts.

The University of Kansas Health System, the University of Kansas Medical Center, Children’s Mercy and BAMF Health announced intentions to establish one of the nation’s first fully integrated Theranostics platforms for both adult and pediatric patients.

Bill was the first patient in the world to participate in a clinical trial exploring an experimental radiopharmaceutical therapy for prostate cancer.

The strategic partnership expands access to precision medicine, molecular imaging, and radiopharmaceutical therapy.

2025 was more than a year of milestones; it was a year of impact. A year of bold advances, compassionate care, and lives touched.

BAMF Health dosed the first patient enrolled in a Phase 1 prostate cancer therapy clinical trial sponsored by ARTBIO.

With a zest and appreciation for life, at 77 years old, Barbara considered herself the picture of perfect health. But that changed in June of 2025 when she was diagnosed with metastatic HR-/HER2+ breast cancer.

Partnership brings new cancer trial and treatments to patients in New York City and Westchester.

We’re among the first centers in the country to treat patients in the new “pre-chemo” setting. Here’s what we’re learning—and what we’re still working to understand.